Anavex Life Sciences (AVXL)
(Delayed Data from NSDQ)
$5.56 USD
+0.07 (1.28%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $5.56 0.00 (0.00%) 6:04 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/25/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | 6.67% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.55 |
Next Year | -0.80 |
EPS (TTM) | -0.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.19 | -0.55 | -0.80 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | -0.17 | -0.19 | -0.55 | -0.80 |
Low Estimate | -0.17 | -0.19 | -0.55 | -0.80 |
Year ago EPS | -0.12 | -0.11 | -0.60 | -0.55 |
Year over Year Growth Est. | -41.67% | -72.73% | 8.33% | -45.45% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.19 | -0.55 | -0.80 |
7 Days Ago | -0.17 | -0.19 | -0.55 | -0.80 |
30 Days Ago | -0.17 | -0.19 | -0.55 | -0.80 |
60 Days Ago | -0.17 | -0.19 | -0.55 | -0.80 |
90 Days Ago | -0.17 | -0.19 | -0.55 | -0.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.19 | -0.55 | -0.80 |
Zacks Consensus Estimate | -0.17 | -0.19 | -0.55 | -0.80 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.13 | -0.11 | -0.12 | NA |
Estimate | -0.15 | -0.13 | -0.15 | -0.16 | NA |
Difference | 0.01 | 0.00 | 0.04 | 0.04 | 0.02 |
Surprise | 6.67% | 0.00% | 26.67% | 25.00% | 14.59% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more